Observational studyAdvances in therapy2024

Real-World Safety and Effectiveness of Infliximab in 255 Patients with Intestinal, Neurological, and Vascular Behçet's Disease: A Post-Marketing Surveillance.

Toshifumi Hibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.